`Tel: 571-272-7822
`
`
`
`
`Paper 17
`Entered: October 11, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`J. KYLE BASS and ERICH SPANGENBERG,
`Petitioner,
`
`v.
`
`ALPEX PHARMA SA,
`Patent Owner.
`_______________
`
`Case IPR2016-00245
`Patent 8,440,170 B2
`_______________
`
`
`
`Before TONI R. SCHEINER, LORA M. GREEN, and
`JACQUELINE WRIGHT BONILLA, Administrative Patent Judges.
`
`GREEN, Administrative Patent Judge.
`
`
`JUDGMENT AND FINAL WRITTEN DECISION
`35 U.S.C. § 318(a) and 37 C.F.R. § 42.73(b)
`
`
`
`
`
`
`
`
`
`IPR2016-00245
`Patent 8,440,170 B2
`
`Petitioner, Messrs. J. Kyle Bass and Erich Spangenberg, filed a
`Petition (Paper 5) requesting an inter partes review of claims 1–9 of U.S.
`Patent No. 8,440,170 B2 (Ex. 1001, “the ’170 patent”). Patent Owner,
`Alpex Pharma SA, filed a Preliminary Response. Paper 12.
`On May 20, 2016, we granted the Petition to institute an inter partes
`review as to claims 1–3, 5, 6, 8, and 9 of the ’170 patent. Paper 13, 19.
`Patent Owner did not file a full Patent Owner Response. Rather, in an email
`dated August 22, 2016, Patent Owner stated that it would not be submitting a
`Response. See Paper 15, 2 (reproducing email of August 22, 2016). In a
`conference call held with the parties on August 22, 2016, Patent Owner
`reiterated what it had said in the email. Id. Accordingly, we ordered Patent
`Owner to show cause as to why adverse judgment should not be entered
`against it. Id. at 3.
`
`Patent Owner filed a response to our order on October 4, 2016. Paper
`16. In that response, Patent Owner confirmed that “it is not inclined, in the
`aftermath of refrainment from filing a response to the Petition, to contest the
`issues designated for trial any further.” Id. at 2. It acknowledged also that
`judgment may be entered against it, premised on the understanding that the
`entry of adverse judgment will “(i) relate solely to the issues designated for
`trial, (ii) result in the cancellation of only ’170 patent claims 1–3, 5, 6, 8, and
`9, and (iii) leave intact ’170 patent claims 4 and 7 which were not designated
`for trial.” Id.
`
`Pursuant to Board rules, “[a]ctions construed to be a request for
`adverse judgment include . . . [a]bandonment of the contest.” 37 C.F.R.
`§ 42.73(b)(4). Patent Owner’s failure to file substantive papers in this trial is
`consistent with abandonment of the contest. As Patent Owner confirms that
`
` 2
`
`
`
`
`
`
`
`IPR2016-00245
`Patent 8,440,170 B2
`
`it will not contest the issues designated for trial, and as Patent Owner’s
`understanding of the consequences of entry of adverse judgment is correct,
`we determine that under these circumstances, the entry of judgment adverse
`to Patent Owner and cancellation of the claims on which trial was instituted
`is appropriate.
`
`ORDER
`In consideration of the foregoing, it is hereby:
`ORDERED that Patent Owner’s request for adverse judgment under
`37 C.F.R. § 42.73(b) with respect to claims 1–3, 5, 6, 8, and 9 of U.S. Patent
`No. 8,440,170 B2 is GRANTED;
`FURTHER ORDERED that this constitutes a final written decision
`under 35 U.S.C. § 318(a); and
`FURTHER ORDERED that claims 1–3, 5, 6, 8, and 9 of U.S. Patent
`No. 8,440,170 B2 be CANCELLED.
`
`
`
`PETITIONER:
`
`Gregory J. Gonsalves
`gonsalves@gonsalveslawfirm.com
`
`PATENT OWNER:
`
`Silvia Salvadori
`silvia@salvadorilaw.com
`George B. Snyder
`gbs@warefressola.com
`
` 3